|
of Northern Virginia, LTD.
M. ANTHONY CASOLARO, MD, FACP Licensure:
Certification:
Subspecialty, Pulmonary Diseases Advanced Cardiac Life Support Advanced Trauma Life Support Education:
Washington, D.C. 1972
B.A. with Honors
M.D. with Honors Professional Experience:
Emory University Hospitals Atlanta, Georgia 1980-1983
Pulmonary Fellow, Pulmonary Branch
Clinical Chief, Senior Staff Investigator, Pulmonary Branch
Pulmonary and Medical Associates of Northern Virginia, Ltd.
Team Physician, Washington Redskins Football Team Honors and Awards:
National Research Service Award Fellowship, Pulmonary Branch National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, Maryland Named best pulmonary physician by the Washingtonian Magazine and Washington Consumer Checkbook Professional Societies:
American College of Chest Physicians National Football League Physician Society 1998 – present Injury and Safety Panel Public Service:
American Lung Association of Northern Virginia 1988-1998
Board of Trustees Teaching Activities:
Georgetown University School of Medicine September 1987-present
Director of Education/Clinical Clerkships
Critical Care Committee
Vice Chairman, Department of Medicine
Co-Director, Critical Care Medicine Education Program
Chairman, Department of Medicine
Vice Chief of Staff Publications:
Casolaro MA, Crystal RG. Interstitial lung disease in the critical care setting. In: Current Therapy in Critical Care Medicine, Parillo J, Ed., BC Decker, Toronto 1987. Wewers MD, Brantly ML, Casolaro MA, Crystal RG. Evaluation of tamoxifen as a therapy to augment alpha 1-antitrypsin levels in Z homozygous alpha 1-antitrypsin deficient individuals. Am Rev Respir Dis; 1987; 135: 401-402. Wewers MD, Casolaro MA, Crystal RG. Comparison of alpha-1 antitrypsin levels and anti-neutrophil elastase capacity of blood and lung in an individual with the alpha 1-antitrypsin phenotype null-null before and during alpha 1-antitrypsin augmentation therapy. Am Rev Respir Dis; 1987; 135: 539-593. Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Crystal RG. Treatment of alpha 1-antitrypsin deficiency associated with emphysema: chronic augmentation of serum and lung alpha 1-antitrypsin levels and anti-neutrophil elastase defenses with weekly parenteral infusions of alpha 1-antitrypsin purified from pooled human plasma. N Engl J Med; 1987; 316: 1055-1062. Ogushi F, Hubbard RC, Fells GA, Casolaro MA, Curiel DT, Brantly ML, Crystal RG. Evaluation of the S type of alpha 1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. Am Rev Respir Dis; 1988; 137: 364-370. Casolaro MA, Fells G, Wewers M, Pierce JE, Ogushsi F, Hubbard R, Sellers S, Forstrom J, Lyons D, Kawasaki G, Crystal RG. Augmentation of primate lung anti-neutrophil elastase capacity with parenteral administration of yeast produced recombinant human alpha 1-antitrypsin. J Appl Physiol; 1987; 63: 2015-2023. Casolaro A, Bernaudin J-F, Saltini C, Ferrans V, Crystal RG. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in association with cigarette smoking. Am Rev Respir Dis; 1988; 137: 406-411. Abstracts:
Honig, EG, Casolaro MA, Panagakos GA, Simon DF. Aerosol bronchodilator efficacy and site specificity in acute asthma. American Review of Respiratory Disease 1983; 127: 134A. Casolaro MA, Honig EG, Panagakos GA. Aerosolized atropine and terbutaline in acute asthma. Chest 1983; 84: 349A. Casolaro, MA, Rennard S, Crystal RG. Protection against neutrophil cathepsin G in the normal human lower respiratory tract. Clinical Research 1984; 426A. Lacronique J, Rennard S, Casolaro A, Wewers M, Straus S, Fells G, Crystal R. Presence of immunoreactive elastase in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis and occupational lung diseases. International Conference on Bronchoalveolar Lavage; Columbia, Maryland; May 1984. Wewers M. Casolaro A, Straus S, Sellers S, McPhaul K, Swayze S, Crystal RG. Alpha 1- antitrypsin deficiency: Reestablishment of the antineutrophil elastase protection by intermittent parenteral alpha 1-antitrypsin therapy. Clinical Research 1985; 33(2): 582A. Casolaro A, Fells G, Wewers M. Pierce J, Crystal R. Augmentation of the lung antielastase defenses of primates with parenteral administration of recombinant DNA produced alpha 1-antitrypsin. Am Rev Resp Dis 1986; 133(4): A103. Wewers M, Casolaro A, Sellers S, McPhaul K, Swayze R, Crystal R. Pulmonary Branch, NHLBI, Alpha 1-antitrypsin (AAT) deficiency replacement study: Chronic augmentation of the antineutrophil elastase capacity of the lower respiratory tract of AAT deficient individuals with weekly infusions of AAT. Am Rev Resp Dis 1986; 133(4): A103. Casolaro A, Arabia F, Sellers S, Newman S, Pellow P, Clarke SW, Matthay M, Pierce J, Clark, RE, Crystal RG. Approaches to therapy of alpha 1-antitrypsin deficiency: Aerosolized recombinant alpha 1-antitrypsisn deposits in the lower respiratory tract and diffuses across the alveolar walls. Clin Res 1987; 35(2). [Rev. January 25, 2005] 
of Northern Virginia, LTD.
|